An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Campa, D, Kaaks, R, Le Marchand, L, Haiman, C, Travis, R, Ziegler, R, Hunter, D, Lindstroem, S, Canzian, F
Μορφή:	Conference item
Έκδοση:	2012

Παρόμοια τεκμήρια

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
ανά: Tsilidis, K, κ.ά.
Έκδοση: (2013)

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
ανά: Lindström, S, κ.ά.
Έκδοση: (2012)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
ανά: Ahn, J, κ.ά.
Έκδοση: (2009)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
ανά: Setiawan, V, κ.ά.
Έκδοση: (2007)

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
ανά: Cox, D, κ.ά.
Έκδοση: (2006)

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
ανά: Lund Eiliv, κ.ά.
Έκδοση: (2009-07-01)

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
ανά: Patel, A, κ.ά.
Έκδοση: (2008)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium
ανά: Campa, D, κ.ά.
Έκδοση: (2011)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
ανά: Campa, D, κ.ά.
Έκδοση: (2011)

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
ανά: Mondul, A, κ.ά.
Έκδοση: (2013)

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
ανά: Barrdahl, M, κ.ά.
Έκδοση: (2014)

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
ανά: Joshi, A, κ.ά.
Έκδοση: (2014)

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
ανά: Machiela, M, κ.ά.
Έκδοση: (2012)

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
ανά: Chen, Y, κ.ά.
Έκδοση: (2007)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
ανά: Lindstrom, S, κ.ά.
Έκδοση: (2011)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
ανά: Shui, I, κ.ά.
Έκδοση: (2014)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
ανά: Lindström, S, κ.ά.
Έκδοση: (2010)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
ανά: Travis, R, κ.ά.
Έκδοση: (2009)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
ανά: Shui, I, κ.ά.
Έκδοση: (2014)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
ανά: Sara Lindstrom, κ.ά.
Έκδοση: (2011-02-01)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
ανά: Mathew, Angelin Tresa, κ.ά.
Έκδοση: (2022)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
ανά: Mathew, Angelin T., κ.ά.
Έκδοση: (2022)

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
ανά: Agarwal, D, κ.ά.
Έκδοση: (2014)

Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
ανά: Tsilidis, K, κ.ά.
Έκδοση: (2012)

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
ανά: Milne, R, κ.ά.
Έκδοση: (2014)

Characteristics of Breast Cancer at First Presentation in Sudanese Patients Attending the National Cancer Institute–University of Gezira (NCI–UG)
ανά: Muna Ahmed Eltayeb, κ.ά.
Έκδοση: (2020-08-01)

Characteristics of Breast Cancer at First Presentation in Sudanese Patients Attending the National Cancer Institute–University of Gezira (NCI–UG)
ανά: Muna Ahmed Eltayeb, κ.ά.
Έκδοση: (2020-08-01)

Haplotypes of the estrogen receptor beta gene and breast cancer risk.
ανά: Cox, D, κ.ά.
Έκδοση: (2008)

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
ανά: Koutros, S, κ.ά.
Έκδοση: (2010)

Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198
ανά: Anna D. Cirac, κ.ά.
Έκδοση: (2017-06-01)

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
ανά: Yang, X, κ.ά.
Έκδοση: (2011)

Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women
ανά: Carolyn Nickson, κ.ά.
Έκδοση: (2018-12-01)

Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.
ανά: Jirong Long, κ.ά.
Έκδοση: (2010-06-01)

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
ανά: Schumacher, F, κ.ά.
Έκδοση: (2007)

The role of osteoprotegerin in breast and prostate cancer
ανά: Holen, I, κ.ά.
Έκδοση: (2002)

The impact of transcription on metabolism in prostate and breast cancers
ανά: Poulose, N, κ.ά.
Έκδοση: (2018)

Frequency of breast cancer subtypes among African American women in the AMBER consortium
ανά: Emma H. Allott, κ.ά.
Έκδοση: (2018-02-01)

The Prostate Cancer Research Consortium Bioresource (Ireland)
ανά: Antony Wekesa, κ.ά.
Έκδοση: (2016-11-01)

Nutrition and breast cancer.
ανά: Key, T, κ.ά.
Έκδοση: (2003)

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
ανά: Foluso O. Ademuyiwa, κ.ά.
Έκδοση: (2022-12-01)